ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

M.D. Anderson Investigator Gave Drug To Patients Without IND; NCI Probes Incident, To Make Report

July 17, 1981

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992